Bahrain receives first batch of AstraZeneca vaccine from India

Bahrain has received its first delivery of the Oxford-AstraZeneca Covid-19 vaccine produced by the Serum Institute of India.

The Covishield vaccine will be free to all citizens and residents.

His Royal Highness Prince Salman bin Hamad Al Khalifa, Crown Prince Prime Minister, thanked Indian Prime Minister Narendra Modi and the Indian Government for working with the Kingdom to secure its delivery.

Prince Salman welcomed the strong partnership between the two countries. He also urged all citizens and residents who have not yet received the vaccination to register for the benefit of themselves, their families and the community.

The National Health Regulatory Authority had earlier approved the emergency use of Covishield vaccine developed by AstraZeneca in co-operation with Oxford University and manufactured by Serum Institute of India.

NHRA chief executive Dr Mariam Al Jalahma had said that the approval follows an in-depth study. She noted that the authority approved the emergency use licence in co-ordination with the manufacturer because it applies quality control procedures and vaccine safety and effectiveness.



Share this page Share on FacebookShare on TwitterShare on Linkedin

Discover the 'Made in France à Bahrain' Guide

'Made in France à Bahrain' - Edition 2021
is YOUR guide to the economic presence in Bahrain. Click here to view the online guide